Most potent antiemetic agent used in preoperative period –
## **Core Concept**
The question tests knowledge of antiemetic agents, specifically those used in the preoperative period to prevent nausea and vomiting. Antiemetics work by blocking various receptors and pathways involved in the vomiting reflex. The potency of antiemetic agents can vary based on their mechanism of action and the specific clinical context.
## **Why the Correct Answer is Right**
Ondansetron, a **5-HT3 receptor antagonist**, is highly effective in preventing nausea and vomiting, especially when induced by chemotherapy, radiation therapy, and surgery. Its mechanism involves blocking the action of serotonin, a natural substance that may cause nausea and vomiting. In the preoperative period, preventing postoperative nausea and vomiting (PONV) is crucial for patient comfort and to reduce the risk of complications. Ondansetron is considered one of the most potent antiemetic agents in this context due to its high efficacy in blocking the 5-HT3 receptors found in the chemoreceptor trigger zone of the central nervous system and in the gastrointestinal tract.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While other antiemetics like metoclopramide have some efficacy, they are not as potent as ondansetron in the preoperative setting for preventing PONV.
- **Option B:** Similarly, other classes of antiemetics may have benefits but are not as effective as ondansetron for this specific indication.
- **Option D:** Without specifying the agent, it's hard to directly refute, but given ondansetron's efficacy, other options are less likely to be correct.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **5-HT3 antagonists like ondansetron** are among the most effective agents for preventing chemotherapy-induced nausea and vomiting (CINV) and PONV. They are often used in combination with other antiemetics for synergistic effects. A classic clinical scenario where ondansetron shines is in the perioperative period for patients undergoing surgeries with a high risk of PONV.
## **Correct Answer:** . Ondansetron